SEC Filings

We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell and gene therapies for patients with high unmet medical need.

Filing date Form Description Filing Group View
D
Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
SC 13G

A statement of beneficial ownership of common stock by certain persons

Other
View HTML
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
S-1/A

Amended Registration statement for face-amount certificate companies

Registration Statements
View HTML
3/A

An amendment to a 3 filing. Non-EDGAR filing

3,4,5
View HTML
SC 13G/A

An amendment to the SC 13G filing

Other
View HTML

Data provided by Kaleidoscope.